Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
+5
New +$585 ﹤0.01% 625
2025
Q2
Sell
-50
Closed -$4K 154
2025
Q1
$4K Buy
+50
New +$4.67K ﹤0.01% 140

Other funds holding MRK

Evolution Advisers's MRK Position: Q2 2026 in Review

Evolution Advisers opened a new position in Merck (MRK) in Q2 2026: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #625 among its holdings. This is a return to the name: Evolution Advisers previously reported a position in MRK as recently as Q1 2025.

Evolution Advisers first reported a position in MRK in Q1 2025 and has held it in 2 quarters since. The position peaked at $4K in Q1 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Evolution Advisers held 5 shares of Merck worth $0 as of Q2 2026.
  • Merck was a new Evolution Advisers position in Q2 2026.
  • Merck made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #625 holding.
  • Evolution Advisers first reported a position in Merck in Q1 2025 and has held it in 2 quarters since.
  • Evolution Advisers's Merck position peaked at $4K in Q1 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.